Gene activity markers in mental health conditions
Part of Mental health clinical trials.
This study looks at how certain molecules (called non-coding RNAs) relate to mental health conditions like bipolar disorder, depression, anxiety, OCD, or schizophrenia. By comparing patients who haven't been on psychiatric medication for at least 6 months with healthy volunteers, researchers hope to find better ways to diagnose and understand these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- If you are a woman, you need to be in the mid-luteal phase of your menstrual cycle (roughly days 19–23 of a regular cycle).
- You must have one of the following diagnoses: bipolar I or II, panic disorder, major depressive disorder, obsessive-compulsive disorder, or schizophrenia.
- You must be newly diagnosed and have never taken psychiatric medication, or you must have been off all psychiatric medications for at least 6 months before joining.
- You must not have serious medical conditions such as autoimmune diseases or active infections, and you must not be on immunosuppressants, antibiotics, or hormone replacement therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how immune cells in your blood (called CD8+ T cells) might be different in people with bipolar disorder. By comparing blood samples from people with bipolar and healthy volunteers, researchers hope to find new clues for diagnosis and treatment.
This study looks for biological markers in the blood or spinal fluid that might predict how well a new psychiatric treatment will work. If you have a psychiatric condition that hasn't improved with previous treatments, this research could help find better ways to match treatments to individuals in the future.
This study is developing more personalized treatments for schizophrenia, depression, or bipolar disorder. It may help find the best treatment approach for your specific situation.
This trial is building a research database that combines genetic information and long-term health data to improve personalized treatment for serious mental illness. You may be eligible if you have been diagnosed or treated for depression, bipolar disorder, schizophrenia, or dementia.
This study collects information about mental health symptoms and body/genetic samples to better understand how different mental health conditions are related. Some people may also have brain scans (PET or MRI) if they can safely complete them.
This study looks at “biopsychosocial markers” (biological, psychological, and social signs) in people with major depression and/or anxiety. It aims to understand what changes with treatment and how those changes connect to symptoms like anxiety and depression.
Hear when a new Schizophrenia Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.